Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent

OBJECTIVES: To analyse the effect of biological agents (BAs) in terms of achieving inactive disease (ID) or clinical remission (CR) in patients with systemic juvenile idiopathic arthritis (SJIA), to describe effects of switching or discontinuing a BA and to assess the proportion of patients able to...

全面介紹

Na minha lista:
書目詳細資料
發表在:RMD Open
Main Authors: Woerner, A, Uettwiller, F, Melki, I, Mouy, R, Wouters, C, Bader-Meunier, B, Quartier, P
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2015
主題:
Paediatric Rheumatology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613174/
https://ncbi.nlm.nih.gov/pubmed/26509061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000036
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍